His primary areas of study are Cancer research, Leukemia, Apoptosis, Immunology and Myeloid leukemia. His Cancer research research is multidisciplinary, incorporating elements of Cancer, Cell culture, In vitro, Downregulation and upregulation and Proteasome. His research integrates issues of Haematopoiesis, Stem cell, Cell growth, Myeloid and Biological activity in his study of Leukemia.
Aaron D. Schimmer focuses mostly in the field of Apoptosis, narrowing it down to topics relating to Cell biology and, in certain cases, GLUT1 and Snf3. The various areas that Aaron D. Schimmer examines in his Immunology study include Internal medicine, Disease and Cellular differentiation. His Myeloid leukemia study integrates concerns from other disciplines, such as Molecular biology, UBA1 and Gene knockdown.
Aaron D. Schimmer mainly investigates Internal medicine, Cancer research, Myeloid leukemia, Leukemia and Pharmacology. His Internal medicine research integrates issues from Gastroenterology, Surgery and Oncology. He combines subjects such as Cancer, Cell cycle, Apoptosis, Cyclin D2 and Immunology with his study of Cancer research.
He has included themes like Molecular biology and Cell biology in his Apoptosis study. His study brings together the fields of Gene knockdown and Myeloid leukemia. His work in Leukemia covers topics such as Stem cell which are related to areas like Mitochondrion.
Myeloid leukemia, Cancer research, Cell biology, Internal medicine and Stem cell are his primary areas of study. The study incorporates disciplines such as DNA damage, Gene knockdown, Nucleoside analogue, Respiratory chain and Metabolism in addition to Myeloid leukemia. His Cancer research research includes elements of UBA1, Ubiquitin, Oxidative phosphorylation, Leukemia and In vivo.
His Leukemia study incorporates themes from Myeloid, Unfolded protein response and Clonogenic assay. His study on Mitochondrion is often connected to Intermembrane space as part of broader study in Cell biology. When carried out as part of a general Internal medicine research project, his work on Induction chemotherapy, Chemotherapy regimen and Chemotherapy is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
Aaron D. Schimmer mainly focuses on Cell biology, Myeloid leukemia, Mitochondrion, Cancer research and Stem cell. His Cell biology study incorporates themes from Regulator, Cytotoxic T cell, Tafazzin and Protease. His Myeloid leukemia research includes themes of Transcript level, Disease monitoring, After treatment, Complete remission and Respiratory chain.
His Mitochondrion study combines topics from a wide range of disciplines, such as Apoptosis, Mitochondrial matrix and Neurotoxicity. Aaron D. Schimmer does research in Cancer research, focusing on Myeloid specifically. His study in Stem cell is interdisciplinary in nature, drawing from both Cell culture and Pyruvate dehydrogenase complex.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Liran I. Shlush;Sasan Zandi;Amanda Mitchell;Weihsu Claire Chen.
Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice
Aaron D. Schimmer.
Cancer Research (2004)
Anoikis resistance and tumor metastasis.
Craig D. Simpson;Craig D. Simpson;Kika Anyiwe;Kika Anyiwe;Aaron D. Schimmer;Aaron D. Schimmer.
Cancer Letters (2008)
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Marko Škrtić;Shrivani Sriskanthadevan;Bozhena Jhas;Marinella Gebbia.
Cancer Cell (2011)
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Stanley W. K. Ng;Amanda Mitchell;James A. Kennedy;James A. Kennedy;James A. Kennedy;Weihsu C. Chen.
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.
Aaron D. Schimmer;Kate Welsh;Clemencia Pinilla;Zhiliang Wang.
Cancer Cell (2004)
Myelodysplastic syndromes: the complexity of stem-cell diseases
Seth J. Corey;Mark D. Minden;Dwayne L. Barber;Hagop M Kantarjian.
Nature Reviews Cancer (2007)
Targeting XIAP for the treatment of malignancy
A D Schimmer;S Dalili;S Dalili;R A Batey;S J Riedl.
Cell Death & Differentiation (2006)
Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
Amy M. Ruschak;Malik Slassi;Lewis E. Kay;Aaron D. Schimmer.
Journal of the National Cancer Institute (2011)
Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.
Olga Berezovskaya;Aaron D. Schimmer;Anna B. Glinskii;Clemencia Pinilla.
Cancer Research (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: